Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Neostigmine Methylsulfate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 47,706Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Dr. Reddy's Laboratories

    02 2ADAPTIS

    03 2American Regent

    04 2Amneal Pharmaceuticals

    05 2Amphastar Pharmaceuticals

    06 2Amring Pharma

    07 4Aurobindo Pharma Limited

    08 2Avet Pharmaceuticals

    09 4Biological E

    10 2Caplin Point Laboratories Limited

    11 2ENDO OPERATIONS

    12 3Exela Pharma Sciences, LLC.

    13 8Farbe Firma

    14 3Fresenius Kabi USA

    15 2Fresenius SE & Co. KGaA

    16 2GLAND PHARMA LIMITED

    17 1Grindeks AS

    18 1Hanlim Pharmaceuticals Inc

    19 3Hikma Pharmaceuticals

    20 1JAMP PHARMA

    21 1Labiana Life Sciences S.A

    22 1Lifespan Biotech

    23 2MARCAN PHARMACEUTICALS INC

    24 2Meitheal Pharmaceuticals

    25 3Omega Laboratories Limited

    26 2Pharmascience Inc.

    27 2Pluviaendo

    28 1Polifarma

    29 2Sagent Pharmaceuticals

    30 2Umedica Laboratories

    31 1Winston Medical Supply

    32 1Zhejiang Xianju Pharmaceutical Co. Ltd

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI India 2024
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2018-07-10

    Application Number : 209135

    Regulatory Info : RX

    Registration Country : USA

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI India 2024
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Packaging :

    Approval Date : 2018-07-10

    Application Number : 209135

    Regulatory Info : RX

    Registration Country : USA

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI India 2024
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 3MG/3ML (1MG/ML)

    Packaging :

    Approval Date : 2022-07-06

    Application Number : 216291

    Regulatory Info : RX

    Registration Country : USA

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    American Regent

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    American Regent

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2018-05-04

    Application Number : 209182

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    American Regent

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    American Regent

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Packaging :

    Approval Date : 2018-05-04

    Application Number : 209182

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Amneal Pharmaceuticals

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Amneal Pharmaceuticals

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2018-06-15

    Application Number : 210051

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Amphastar Pharmaceuticals

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Amphastar Pharmaceuticals

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2017-09-25

    Application Number : 209933

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Amphastar Pharmaceuticals

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Amphastar Pharmaceuticals

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Packaging :

    Approval Date : 2017-09-25

    Application Number : 209933

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Avet Pharmaceuticals

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Avet Pharmaceuticals

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2022-11-25

    Application Number : 208230

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Avet Pharmaceuticals

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Avet Pharmaceuticals

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Packaging :

    Approval Date : 2022-11-25

    Application Number : 208230

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    11

    Exela Pharma Sciences, LLC.

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Exela Pharma Sciences, LLC.

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : BLOXIVERZ

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2013-05-31

    Application Number : 204078

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    12

    Exela Pharma Sciences, LLC.

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Exela Pharma Sciences, LLC.

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : BLOXIVERZ

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Packaging :

    Approval Date : 2013-05-31

    Application Number : 204078

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    13

    Exela Pharma Sciences, LLC.

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Exela Pharma Sciences, LLC.

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : BLOXIVERZ

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/5ML (1MG/ML)

    Packaging :

    Approval Date : 2023-10-27

    Application Number : 204078

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    14

    Fresenius Kabi USA

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Fresenius Kabi USA

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2015-01-08

    Application Number : 203629

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    15

    Fresenius Kabi USA

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Fresenius Kabi USA

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Packaging :

    Approval Date : 2015-01-08

    Application Number : 203629

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    16

    Fresenius Kabi USA

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Fresenius Kabi USA

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 3MG/3ML (1MG/ML)

    Packaging :

    Approval Date : 2018-09-18

    Application Number : 203629

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    17

    Hikma Pharmaceuticals

    United Kingdom
    2024 ACI Convention
    Not Confirmed
    arrow

    Hikma Pharmaceuticals

    United Kingdom
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2015-12-28

    Application Number : 207042

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    18

    Hikma Pharmaceuticals

    United Kingdom
    2024 ACI Convention
    Not Confirmed
    arrow

    Hikma Pharmaceuticals

    United Kingdom
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Packaging :

    Approval Date : 2015-12-28

    Application Number : 207042

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    19

    ENDO OPERATIONS

    Country
    2024 ACI Convention
    Not Confirmed
    arrow

    ENDO OPERATIONS

    Country
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Packaging :

    Approval Date : 2017-04-26

    Application Number : 208405

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    20

    ENDO OPERATIONS

    Country
    2024 ACI Convention
    Not Confirmed
    arrow

    ENDO OPERATIONS

    Country
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Packaging :

    Approval Date : 2017-04-26

    Application Number : 208405

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF